Simple Summary Oligometastatic disease is a condition in oncology where cancer affects
only a few distant sites. It is associated with a low-burden spread and a more favorable …

Stereotactic body radiotherapy (SBRT) has emerged as a technique to treat
oligoprogressive sites among patients with breast cancer who are otherwise doing well on …

Background: Emerging data have supported the immunostimulatory role of radiotherapy,
which could exert a synergistic effect with immune checkpoint inhibitors (ICIs). With proven …

De novo metastatic breast cancer represents 5 to 8% of all breast cancers (2500 new cases
per year in France). Systemic treatment is the cornerstone of treatment, whereas radiation …

Metastatic breast cancer (MBC) is still an incurable disease, which eventually develops
resistance mechanisms against systemic therapies. While most patients experience …

Purpose We examine the potential for curative approaches among metastatic breast cancer
(MBC) patients by exploring the recent literature on local ablative therapies like surgery and …

Introduction The aim of this systematic review and meta-analysis was to review evidence
and pool outcomes to assess the effectiveness of stereotactic ablative radiotherapy (SABR) …

Introduction: Radiotherapy (RT) shows potential for improving local control in cases of
oligoprogressive metastatic breast cancer (mBC). This retrospective analysis aims to …

Aims Evidence shows stereotactic ablative body radiotherapy (SABR) is used as a non-
invasive ablative therapy in the treatment of multisite oligometastatic (OM) and …

Background: Emerging data have supported the immunostimulatory role of radiotherapy,
which could exert a synergistic effect with immune checkpoint inhibitors (ICIs). With proven …